{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:47:21Z","timestamp":1793724441990,"version":"4.6.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"This work is funded by Hunan Natural Science Foundation","award":["2021JJ70141"],"award-info":[{"award-number":["2021JJ70141"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"DOI":"10.1186\/s12902-026-02176-3","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T06:23:12Z","timestamp":1769581392000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Urinary 8-hydroxy-2\u2019-deoxyguanosine as an early predictive biomarker for glomerular filtration rate decline in patients with type 2 diabetes mellitus"],"prefix":"10.1186","volume":"26","author":[{"given":"Juan","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,28]]},"reference":[{"key":"2176_CR1","doi-asserted-by":"crossref","unstructured":"ElSayed NA, Aleppo G, Aroda VR, et al. Chronic kidney disease and risk management: standards of care in diabetes-2025. Diabetes Care. 2025;48(Suppl 1):S239-S255.","DOI":"10.2337\/dc25-S011"},{"issue":"12","key":"2176_CR2","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.2215\/CJN.11491116","volume":"12","author":"RZ Alicic","year":"2017","unstructured":"Alicic RZ, Rooney MT, Tuttle KR. Diabetic kidney disease: Challenges, progress, and possibilities. Clin J Am Soc Nephrol. 2017;12(12):2032\u201345.","journal-title":"Clin J Am Soc Nephrol"},{"key":"2176_CR3","doi-asserted-by":"publisher","first-page":"1497449","DOI":"10.1155\/2021\/1497449","volume":"2021","author":"N Samsu","year":"2021","unstructured":"Samsu N. Diabetic nephropathy: challenges in pathogenesis, diagnosis, and treatment. BioMed Res Int. 2021;2021:1497449.","journal-title":"BioMed Res Int"},{"issue":"9844","key":"2176_CR4","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/S0140-6736(12)60572-8","volume":"380","author":"M Tonelli","year":"2012","unstructured":"Tonelli M, Muntner P, Lloyd A, et al. Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study. Lancet. 2012;380(9844):807\u201314.","journal-title":"Lancet"},{"issue":"2","key":"2176_CR5","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/nrneph.2015.173","volume":"12","author":"MC Thomas","year":"2016","unstructured":"Thomas MC, Cooper ME, Zimmet P. Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease. Nat Rev Nephrol. 2016;12(2):73\u201381.","journal-title":"Nat Rev Nephrol"},{"key":"2176_CR6","doi-asserted-by":"crossref","unstructured":"Bennett JE, Stevens GA, Mathers CD, et al. NCD Countdown. 2030: worldwide trends in non-communicable disease mortality and progress towards sustainable development goal target 3.4. Lancet. 2018;392(10152):1072\u20131088.","DOI":"10.1016\/S0140-6736(18)31992-5"},{"issue":"3","key":"2176_CR7","doi-asserted-by":"publisher","first-page":"867","DOI":"10.2337\/dc13-1870","volume":"37","author":"GL Bakris","year":"2014","unstructured":"Bakris GL, Molitch M. Microalbuminuria as a risk predictor in diabetes: the continuing Saga. Diabetes Care. 2014;37(3):867\u201375.","journal-title":"Diabetes Care"},{"issue":"2","key":"2176_CR8","doi-asserted-by":"publisher","first-page":"248","DOI":"10.2337\/dbi18-0007","volume":"68","author":"RZ Alicic","year":"2019","unstructured":"Alicic RZ, Neumiller JJ, Johnson EJ, Dieter B, Tuttle KR. Sodium-Glucose cotransporter 2 Inhibition and diabetic kidney disease. Diabetes. 2019;68(2):248\u201357.","journal-title":"Diabetes"},{"issue":"11","key":"2176_CR9","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.2337\/diab.43.11.1358","volume":"43","author":"P Fioretto","year":"1994","unstructured":"Fioretto P, Steffes MW, Mauer M. Glomerular structure in nonproteinuric IDDM patients with various levels of albuminuria. Diabetes. 1994;43(11):1358\u201364.","journal-title":"Diabetes"},{"issue":"11","key":"2176_CR10","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.numecd.2019.07.017","volume":"29","author":"G Pugliese","year":"2019","unstructured":"Pugliese G, Penno G, Natali A, et al. Diabetic kidney disease: new clinical and therapeutic issues. Joint position statement of the Italian diabetes society and the Italian society of nephrology on the natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function. Nutr Metab Cardiovasc Dis. 2019;29(11):1127\u201350.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"5","key":"2176_CR11","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1007\/s00125-018-4567-5","volume":"61","author":"HM Colhoun","year":"2018","unstructured":"Colhoun HM, Marcovecchio ML. Biomarkers of diabetic kidney disease. Diabetologia. 2018;61(5):996\u20131011.","journal-title":"Diabetologia"},{"key":"2176_CR12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s41512-018-0035-4","volume":"2","author":"BG Feakins","year":"2018","unstructured":"Feakins BG, McFadden EC, Farmer AJ, Stevens RJ. Standard and competing risk analysis of the effect of albuminuria on cardiovascular and cancer mortality in patients with type 2 diabetes mellitus. Diagn Progn Res. 2018;2:13.","journal-title":"Diagn Progn Res"},{"issue":"4","key":"2176_CR13","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3390\/antiox13040455","volume":"13","author":"N Wang","year":"2024","unstructured":"Wang N, Zhang C. Oxidative stress: A culprit in the progression of diabetic kidney disease. Antioxid (Basel). 2024;13(4):455.","journal-title":"Antioxid (Basel)"},{"key":"2176_CR14","doi-asserted-by":"publisher","first-page":"121661","DOI":"10.1016\/j.lfs.2023.121661","volume":"322","author":"S Su","year":"2023","unstructured":"Su S, Ma Z, Wu H, et al. Oxidative stress as a culprit in diabetic kidney disease. Life Sci. 2023;322:121661.","journal-title":"Life Sci"},{"key":"2176_CR15","doi-asserted-by":"publisher","first-page":"1134325","DOI":"10.3389\/fendo.2023.1134325","volume":"14","author":"M Zhong","year":"2023","unstructured":"Zhong M, Zhu E, Li N, et al. Identification of diagnostic markers related to oxidative stress and inflammatory response in diabetic kidney disease by machine learning algorithms: evidence from human transcriptomic data and mouse experiments. Front Endocrinol (Lausanne). 2023;14:1134325.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7","key":"2176_CR16","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.3390\/antiox10071143","volume":"10","author":"M Sakashita","year":"2021","unstructured":"Sakashita M, Tanaka T, Inagi R. Metabolic changes and oxidative stress in diabetic kidney disease. Antioxid (Basel). 2021;10(7):1143.","journal-title":"Antioxid (Basel)"},{"issue":"10","key":"2176_CR17","doi-asserted-by":"publisher","first-page":"925","DOI":"10.3390\/antiox9100925","volume":"9","author":"NV Hojs","year":"2020","unstructured":"Hojs NV, Bevc S, Ekart R, et al. Oxidative stress markers in chronic kidney disease with emphasis on diabetic nephropathy. Antioxid (Basel). 2020;9(10):925.","journal-title":"Antioxid (Basel)"},{"issue":"10","key":"2176_CR18","doi-asserted-by":"publisher","first-page":"925","DOI":"10.3390\/antiox9100925","volume":"9","author":"N Vodo\u0161ek Hojs","year":"2020","unstructured":"Vodo\u0161ek Hojs N, Bevc S, Ekart R, Hojs R. Oxidative stress markers in chronic kidney disease with emphasis on diabetic nephropathy. Antioxid (Basel). 2020;9(10):925.","journal-title":"Antioxid (Basel)"},{"issue":"4","key":"2176_CR19","doi-asserted-by":"publisher","first-page":"583","DOI":"10.3390\/cells12040583","volume":"12","author":"S Rajlic","year":"2023","unstructured":"Rajlic S, Treede H, M\u00fcnzel T, et al. Early detection is the best prevention\u2014characterization of oxidative stress in diabetes mellitus and its consequences on the cardiovascular system. Cells. 2023;12(4):583.","journal-title":"Cells"},{"issue":"5","key":"2176_CR20","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s11684-019-0729-1","volume":"14","author":"P Zhang","year":"2020","unstructured":"Zhang P, Li T, Wu X, et al. Oxidative stress and diabetes: antioxidative strategies. Front Med. 2020;14(5):583\u2013600.","journal-title":"Front Med"},{"issue":"6","key":"2176_CR21","first-page":"405","volume":"67","author":"M Zaki","year":"2024","unstructured":"Zaki M, Abdallah H, Orban H, et al. Assessment of urinary 8-hydroxy-2-deoxyguanosine as oxidative DNA damage for diabetic nephropathy. Egypt J Chem. 2024;67(6):405\u20138.","journal-title":"Egypt J Chem"},{"issue":"10","key":"2176_CR22","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.3109\/10715762.2012.710902","volume":"46","author":"M Serdar","year":"2012","unstructured":"Serdar M, Sertoglu E, Uyanik M, et al. Comparison of 8-hydroxy-2\u2019-deoxyguanosine (8-OHdG) levels using mass spectrometer and urine albumin creatinine ratio as a predictor of development of diabetic nephropathy. Free Radic Res. 2012;46(10):1291\u20135.","journal-title":"Free Radic Res"},{"issue":"2","key":"2176_CR23","doi-asserted-by":"publisher","first-page":"103722","DOI":"10.1016\/j.numecd.2024.08.015","volume":"35","author":"B Spoto","year":"2025","unstructured":"Spoto B, Politi C, Pizzini P, et al. 8-hydroxy-2\u2019-deoxyguanosine, a biomarker of oxidative DNA injury, in diabetic kidney disease. Nutr Metab Cardiovasc Dis. 2025;35(2):103722.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"4","key":"2176_CR24","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s00125-017-4510-1","volume":"61","author":"M Sanchez","year":"2018","unstructured":"Sanchez M, Roussel R, Hadjadj S, et al. Plasma concentrations of 8-hydroxy-2\u2019-deoxyguanosine and risk of kidney disease and death in individuals with type 1 diabetes. Diabetologia. 2018;61(4):977\u201384.","journal-title":"Diabetologia"},{"issue":"17","key":"2176_CR25","doi-asserted-by":"publisher","first-page":"13541","DOI":"10.3390\/ijms241713541","volume":"24","author":"P Goycheva","year":"2023","unstructured":"Goycheva P, Petkova-Parlapanska K, Georgieva E, et al. Biomarkers of oxidative stress in diabetes mellitus with diabetic nephropathy complications. Int J Mol Sci. 2023;24(17):13541.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2176_CR26","doi-asserted-by":"publisher","first-page":"2146512","DOI":"10.1080\/0886022X.2022.2146512","volume":"45","author":"X Ma","year":"2023","unstructured":"Ma X, Ma J, Leng T, et al. Advances in oxidative stress in pathogenesis of diabetic kidney disease and efficacy of TCM intervention. Ren Fail. 2023;45(1):2146512.","journal-title":"Ren Fail"},{"key":"2176_CR27","doi-asserted-by":"crossref","unstructured":"From the American Association of Neurological Surgeons (AANS), American Society of Neuroradiology (ASNR), Cardiovascular and Interventional Radiology Society of Europe (CIRSE), Canadian Interventional Radiology Association (CIRA), Congress of Neurological Surgeons (CNS), European Society of Minimally Invasive Neurological Therapy (ESMINT), European Society of Neuroradiology (ESNR), European Stroke Organization (ESO), Society for Cardiovascular Angiography and Interventions (SCAI), Society of Interventional Radiology (SIR), Society of NeuroInterventional Surgery (SNIS), and World Stroke Organization (WSO), Sacks D, Baxter B, et al. Multisociety consensus quality improvement revised consensus statement for endovascular therapy of acute ischemic stroke. Int J Stroke. 2018;13(6):612\u2013632.","DOI":"10.1177\/1747493018778713"},{"issue":"1","key":"2176_CR28","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s13098-023-01057-2","volume":"15","author":"M Zarezadeh","year":"2023","unstructured":"Zarezadeh M, Musazadeh V, Foroumandi E, Keramati M, Ostadrahimi A, Mekary RA. The effect of cinnamon supplementation on glycemic control in patients with type 2 diabetes or with polycystic ovary syndrome: an umbrella meta-analysis on interventional meta-analyses. Diabetol Metab Syndr. 2023;15(1):127.","journal-title":"Diabetol Metab Syndr"},{"key":"2176_CR29","doi-asserted-by":"publisher","first-page":"220380","DOI":"10.5888\/pcd20.220380","volume":"20","author":"A Gonz\u00e1lez-Rocha","year":"2023","unstructured":"Gonz\u00e1lez-Rocha A, Colli VA, Denova-Guti\u00e9rrez E. Risk prediction score for chronic kidney disease in healthy adults and adults with type 2 diabetes: systematic review. Prev Chronic Dis. 2023;20:220380.","journal-title":"Prev Chronic Dis"},{"issue":"4","key":"2176_CR30","doi-asserted-by":"publisher","first-page":"e355","DOI":"10.1002\/ctd2.355","volume":"4","author":"L Yang","year":"2024","unstructured":"Yang L, Wu Y, Wang Y, et al. Prediction factors and models for chronic kidney disease in type 2 diabetes mellitus: A review of the literature. Clin Transl Discov. 2024;4(4):e355.","journal-title":"Clin Transl Discov"},{"issue":"4","key":"2176_CR31","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1007\/s11255-022-03354-7","volume":"55","author":"SM Swaminathan","year":"2023","unstructured":"Swaminathan SM, Rao IR, Shenoy SV, et al. Novel biomarkers for prognosticating diabetic kidney disease progression. Int Urol Nephrol. 2023;55(4):913\u201328.","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"2176_CR32","first-page":"1934578X2513217","volume":"20","author":"Y Chen","year":"2025","unstructured":"Chen Y, Liu X, Shengbu M, et al. Biomarkers: new advances in diabetic nephropathy. Nat Prod Commun. 2025;20(1):1934578X251321758.","journal-title":"Nat Prod Commun"},{"issue":"6","key":"2176_CR33","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1007\/s11255-021-03031-1","volume":"54","author":"M Kova\u010devi\u0107","year":"2022","unstructured":"Kova\u010devi\u0107 M, Mali\u0161 S, Pavlovi\u0107 D, et al. Plasma activity of the antioxidant enzymes in predicting diabetic nephropathy progression. Int Urol Nephrol. 2022;54(6):1365\u201372.","journal-title":"Int Urol Nephrol"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-026-02176-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02176-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02176-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T13:57:37Z","timestamp":1771595857000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12902-026-02176-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,28]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2176"],"URL":"https:\/\/doi.org\/10.1186\/s12902-026-02176-3","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,28]]},"assertion":[{"value":"9 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol received approval from the Xiangya Hospital of Central South University ethics committee, and all participants provided written informed consent prior to enrollment. The study adhered to the principles outlined in the Declaration of Helsinki and followed the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"71"}}